Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism

Atherosclerosis

Volumn 214, Issue 2, 2011, Pages 448-455

  Karuna, Ratna ^a,b   Holleboom, Adriaan G ^c   Motazacker, Mohammad M ^c   Kuivenhoven, Jan Albert ^c   Frikke Schmidt, Ruth ^d   Tybjaerg Hansen, Anne ^d   Georgopoulos, Spiros ^e   van Eck, Miranda ^f   Van Berkel, Theo J C ^f   von Eckardstein, Arnold ^a,b   Rentsch, Katharina M ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d Rigshospitalet   (Denmark)

^e BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^f LEIDEN UNIVERSITY   (Netherlands)

Author keywords

High density lipoproteins; Lecithin:cholesterol acyltransferase; Mass spectrometry; Monogenic disease; Oxysterols; Reverse cholesterol transport

Indexed keywords

26 HYDROXYCHOLESTEROL; ABC TRANSPORTER; APOLIPOPROTEIN A1; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIVER TRIACYLGLYCEROL LIPASE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; SCAVENGER RECEPTOR BI;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ESTERIFICATION; FEMALE; GENE MUTATION; HETEROZYGOSITY; HUMAN; KNOCKOUT MOUSE; LIPOPROTEIN DEFICIENCY; LIPOPROTEIN METABOLISM; MALE; MONOGENIC DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN LOCALIZATION;

ADOLESCENT; ADULT; AGED; ANIMALS; APOLIPOPROTEIN A-I; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; FEMALE; GENOTYPE; HUMANS; HYDROXYCHOLESTEROLS; LIPASE; LIPID METABOLISM, INBORN ERRORS; LIPOPROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MIDDLE AGED; MUTATION; PHENOTYPE; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; SCAVENGER RECEPTORS, CLASS B; YOUNG ADULT;

EID: 79151470239     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.10.042     Document Type: Article

References (30)

1. Babiker A., Andersson O., Lund E., et al. Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism. Comparison with high density lipoprotein-mediated reverse cholesterol transport. J Biol Chem 1997, 272:26253-26261.
2. Bjorkhem I. Do oxysterols control cholesterol homeostasis?. J Clin Invest 2002, 110:725-730.
3. Meaney S., Bodin K., Diczfalusy U., Bjorkhem I. On the rate of translocation in vitro and kinetics in vivo of the major oxysterols in human circulation: critical importance of the position of the oxygen function. J Lipid Res 2002, 43:2130-2135.
4. Bjorkhem I., Meaney S., Diczfalusy U. Oxysterols in human circulation: which role do they have?. Curr Opin Lipidol 2002, 13:247-253.
5. Chawla A., Repa J.J., Evans R.M., Mangelsdorf D.J. Nuclear receptors and lipid physiology: opening the X-files. Science 2001, 294:1866-1870.
6. DuSell C.D., McDonnell D.P. 27-Hydroxycholesterol: a potential endogenous regulator of estrogen receptor signaling. Trends Pharmacol Sci 2008, 29:510-514.
7. Vaya J., Aviram M., Mahmood S., et al. Selective distribution of oxysterols in atherosclerotic lesions and human plasma lipoproteins. Free Radic Res 2001, 34:485-497.
8. Weingartner O., Laufs U., Bohm M., Lutjohann D. An alternative pathway of reverse cholesterol transport: the oxysterol 27-hydroxycholesterol. Atherosclerosis 2010, 209:39-41.
9. Burkard I., von Eckardstein A., Waeber G., Vollenweider P., Rentsch K.M. Lipoprotein distribution and biological variation of 24S- and 27-hydroxycholesterol in healthy volunteers. Atherosclerosis 2007, 194:71-78.
10. Karuna R., von Eckardstein A., Rentsch K.M. Dopant assisted-atmospheric pressure photoionization (DA-APPI) liquid chromatography-mass spectrometry for the quantification of 27-hydroxycholesterol in plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2009, 877:261-268.
11. von Eckardstein A., Nofer J.R., Assmann G. High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 2001, 21:13-27.
12. Kuivenhoven J.A., Hovingh G.K., van Tol A., et al. Heterozygosity for ABCA1 gene mutations: effects on enzymes, apolipoproteins and lipoprotein particle size. Atherosclerosis 2003, 171:311-319.
13. Hovingh G.K, Brownlie A., Bisoendial R.J., et al. A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease. J Am Coll Cardiol 2004, 44:1429-1435.
14. Hovingh G.K., de Groot E., van der Steeg W., et al. Inherited disorders of HDL metabolism and atherosclerosis. Curr Opin Lipidol 2005, 16:139-145.
15. Kuivenhoven J.A., Weibusch H., Pritchard P.H., et al. An intronic mutation in a lariat branchpoint sequence is a direct cause of an inherited human disorder (fish-eye disease). J Clin Invest 1996, 98:358-364.
16. van der Steeg W.A., Hovingh G.K., Klerkx A.H., et al. Cholesterylester transfer protein and hyperalphalipoproteinemia in Caucasians. J Lipid Res 2007, 48:674-682.
17. Out R., Hoekstra M., Habets K., et al. Combined deletion of macrophage ABCA1 and ABCG1 leads to massive lipid accumulation in tissue macrophages and distinct atherosclerosis at relatively low plasma cholesterol levels. Arterioscler Thromb Vasc Biol 2008, 28:258-264.
18. Warnick G.R., Benderson J., Albers J.J. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 1982, 28:1379-1388.
19. Frohlich J., McLeod R., Pritchard P.H., Fesmire J., McConathy W. Plasma lipoprotein abnormalities in heterozygotes for familial lecithin:cholesterol acyltransferase deficiency. Metabolism 1988, 37:3-8.
20. Niemeijer-Kanters S.D., Dallinga-Thie G.M., Ruijter-Heijstek F.C., et al. Effect of intensive lipid-lowering strategy on low-density lipoprotein particle size in patients with type 2 diabetes mellitus. Atherosclerosis 2001, 156:209-216.
21. DuSell C.D., Nelson E.R., Wang X., et al. The endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasis. Endocrinology 2010, 151:3675-3685.
22. Jones D.R., Schmidt R.J., Pickard R.T., Foxworthy P.S., Eacho P.I. Estrogen receptor-mediated repression of human hepatic lipase gene transcription. J Lipid Res 2002, 43:383-391.
23. Lopez D., McLean M.P. Estrogen regulation of the scavenger receptor class B gene: anti-atherogenic or steroidogenic, is there a priority?. Mol Cell Endocrinol 2006, 247:22-33.
24. Tam S.P, Mok L., Chimini G., Vasa M., Deeley R.G. ABCA1 mediates high-affinity uptake of 25-hydroxycholesterol by membrane vesicles and rapid efflux of oxysterol by intact cells. Am J Physiol Cell Physiol 2006, 291:C490-502.
25. Terasaka N., Yu S., Yvan-Charvet L., et al. ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet. J Clin Invest 2008, 118:3701-3713.
26. Zhao Y., Van Berkel T.J., Van Eck M. Relative roles of various efflux pathways in net cholesterol efflux from macrophage foam cells in atherosclerotic lesions. Curr Opin Lipidol 2010, 21:441-453.
27. Szedlacsek S.E., Wasowicz E., Hulea S.A., Nishida H.I., Kummerow F.A., Nishida T. Esterification of oxysterols by human plasma lecithin-cholesterol acyltransferase. J Biol Chem 1995, 270:11812-11819.
28. Chang C., Dong R., Miyazaki A., et al. Human acyl-CoA:cholesterol acyltransferase (ACAT) and its potential as a target for pharmaceutical intervention against atherosclerosis. Acta Biochim Biophys Sin (Shanghai) 2006, 38:151-156.
29. Zhang Y., Yu C., Liu J., Spencer T.A., Chang C.C., Chang T.Y. Cholesterol is superior to 7-ketocholesterol or 7 alpha-hydroxycholesterol as an allosteric activator for acyl-coenzyme A:cholesterol acyltransferase 1. J Biol Chem 2003, 278:11642-11647.
30. Lin C.Y., Morel D.W. Esterification of oxysterols in human serum: effects on distribution and cellular uptake. J Lipid Res 1996, 37:168-178.